Naples Doctor Who Operated a Pill Mill Sentenced to Three Years in Federal Prison
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Naples Doctor Who Operated a Pill Mill Sentenced to Three Years in Federal Prison

Naples Doctor Who Operated a Pill Mill Sentenced to Three Years in Federal Prison

December 06, 2021
|
Share Article
|
Download Press Release
For Immediate Release
Contact:
Phone Number: (571) 362-3364 - Option 5

Ordered to Forfeit More Than $400,000 and Nine Luxury Vehicles

FORT MYERS, Fla. – U.S. District Judge Sheri Polster Chappell today sentenced Gerald Michael Abraham, 76, of Naples, Florida. to three years in federal prison for dispensing controlled substances (oxycodone and amphetamine) for no legitimate medical purpose. The court also ordered Abraham to forfeit the following items to the United States, which were proceeds of his illegal activities: a 2020 Acura NSX, a 2020 Porsche GT4, a 2021 Toyota Supra, a 2020 Chevrolet Corvette, a 2020 Aston Martin, a 2020 Nissan 370Z, a 2020 Chevrolet Camaro, two 2020 Ford Mustangs, $190,496.56 paid towards a 2021 Aston Martin, and $249,598.52 in cash.

According to court documents, Abraham was a licensed psychiatrist who practiced in Naples, Fla. His clinic operated on a cash only basis, with patients paying $400 per visit.

In October 2019, the Drug Enforcement Administration (DEA) began an investigation after receiving a tip that Abraham was illegally prescribing strong opioids to patients who had no need for the medication. Over the course of the next year, DEA conducted 18 undercover patient visits to Abraham’s office, each time receiving prescriptions for oxycodone. Abraham ignored signs of drug abuse the undercover patients pretended to have and prescribed them oxycodone without ever examining them. Additionally, Abraham repeatedly increased the strength of the prescriptions simply because the patient asked him for more. In one instance, he prescribed an undercover patient oxycodone after telling him the medical paperwork “shows you are completely normal.”

The investigation also revealed that Abraham frequently prescribed Adderall to patients for no legitimate reason. Adderall is the brand name of a drug used to treat attention deficit hyperactivity disorder and contains amphetamine, a frequently abused controlled substance. On multiple occasions, law enforcement observed Abraham prescribe Adderall simply upon a patient’s request, without asking any questions or engaging in any examination justifying the prescription.

This case was investigated by the Drug Enforcement Administration Miami Field Division and the United States Secret Service, with assistance from the Naples Police Department and the Charlotte County Sheriff’s Office. Prosecution and forfeiture were handled by the U.S. Attorney’s Office for the Middle District of Florida.

More information about this case can be found at https://www.flmd.uscourts.gov or https://ecf.flmd.uscourts.gov. 

 

Download Press Release
###
Oxycodone Amphetamines
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Deanne L. Reuter Special Agent in Charge - Miami
@deamiamidiv
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster